(3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine

C27H30F3N7O2 — CID 118890768

IUPAC(3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine
SMILESCCn1nc(C(F)(F)F)cc1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccnn3C3CCCCO3)nccc12
InChIInChI=1S/C27H30F3N7O2/c1-3-36-21(15-22(34-36)27(28,29)30)19-14-23(35-11-13-38-16-17(35)2)33-25-18(19)7-9-31-26(25)20-8-10-32-37(20)24-6-4-5-12-39-24/h7-10,14-15,17,24H,3-6,11-13,16H2,1-2H3/t17-,24?/m1/s1
InChIKeyODZWLCNZSUPKRU-BPNWFJGMSA-N
MW541.58 g/mol
LogP5.32
Rot. Bonds5

About (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine

(3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine (PubChem CID 118890768) has the molecular formula C27H30F3N7O2 and a molecular weight of 541.58 g/mol. Its IUPAC name is (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine.

Molecular Properties

Compound Name(3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine
PubChem CID118890768
Molecular FormulaC27H30F3N7O2
Molecular Weight541.58 g/mol
Exact Mass541.24
IUPAC Name(3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine
SMILESCCn1nc(C(F)(F)F)cc1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccnn3C3CCCCO3)nccc12
InChIInChI=1S/C27H30F3N7O2/c1-3-36-21(15-22(34-36)27(28,29)30)19-14-23(35-11-13-38-16-17(35)2)33-25-18(19)7-9-31-26(25)20-8-10-32-37(20)24-6-4-5-12-39-24/h7-10,14-15,17,24H,3-6,11-13,16H2,1-2H3/t17-,24?/m1/s1
InChIKeyODZWLCNZSUPKRU-BPNWFJGMSA-N
XLogP5.32
TPSA83.12 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms39
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500541.58
LogP ≤ 55.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Analyze (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Elimusertib
CID 118869362
4-[6-[5-(1-ethylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-2-pyridinyl]morpholine
CID 71253640
(3R)-3-methyl-4-[1-methyl-6-(1H-pyrrolo[2,3-d]pyridazin-4-yl)imidazo[4,5-c]pyridin-4-yl]morpholine
CID 118720891
US10023576, Example 63
CID 130362847
7-(1-methylpyrazol-4-yl)-N-[[(2S)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine
CID 66556035
4-[2-Methyl-3-[1-(quinolin-2-ylmethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]morpholine
CID 71139236
US10772893, Example 143
CID 118869117
US10772893, Example 82
CID 118869234
(3R)-3-methyl-4-[4-(oxan-4-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
CID 118869550
CID 118869552
CID 118869552
US10772893, Example 118
CID 118890739
(3R)-4-[4-(2-fluoro-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]-3-methylmorpholine
CID 122585589

Frequently Asked Questions

What is the IUPAC name of (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine?
The IUPAC name of (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine (CID 118890768) is (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine.
What is the SMILES notation for (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine?
The canonical SMILES for (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine is CCn1nc(C(F)(F)F)cc1-c1cc(N2CCOC[C@H]2C)nc2c(-c3ccnn3C3CCCCO3)nccc12.
What is the InChIKey of (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine?
The InChIKey is ODZWLCNZSUPKRU-BPNWFJGMSA-N. The full InChI is InChI=1S/C27H30F3N7O2/c1-3-36-21(15-22(34-36)27(28,29)30)19-14-23(35-11-13-38-16-17(35)2)33-25-18(19)7-9-31-26(25)20-8-10-32-37(20)24-6-4-5-12-39-24/h7-10,14-15,17,24H,3-6,11-13,16H2,1-2H3/t17-,24?/m1/s1.
What are the key properties of (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine?
(3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine has a molecular weight of 541.58 g/mol, XLogP of 5.32, 5 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-4-[4-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-8-[2-(oxan-2-yl)pyrazol-3-yl]-1,7-naphthyridin-2-yl]-3-methylmorpholine is sourced from PubChem (CID 118890768), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).